SOLICITATION NOTICE
66 -- Aerosol Detector
- Notice Date
- 6/3/2009
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- 1057621
- Archive Date
- 7/3/2009
- Point of Contact
- Jaclyn Stielper, , Doreen Williams , Phone: 301-827-3366
- E-Mail Address
-
jaclyn.stielper@fda.hhs.gov, doreen.williams@fda.hhs.gov
(jaclyn.stielper@fda.hhs.gov, doreen.williams@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6, simplified acquisition procedures and the resultant purchase order will include all applicable provisions and clauses in effect through the Federal Acquisition Circular 05-30. This announcement constitutes the only 100% total small business side aside solicitation and a written solicitation will not be issued. This synopsis, NAICS code 334516, is to notify contractors that the government intends to issue a Firm Fixed Price Purchase Order in accordance with FAR Part 13.106 for the following statement of work, under the simplified acquisition procedures. Any firm that believes it is capable of providing the required service as stated herein may submit a capability statement to document its ability to provide the required services. A determination to compete this procurement based on a response to this notice is solely within the discretion of the Government. The Government reserves the right to award a contract without discussions if the Contracting Officer determines that the initial offer(s) is/are providing the Best Value and discussions are not necessary. Award will be made to the party whose quote offers the best value to the Government, technical, price, and other factors considered. The Government may award this contract to other than the lowest price technically acceptable quote. The Government will evaluate information based on the following evaluation criteria: 1) Technical Capability factor described to "Meet or Exceed the Requirement," 2) Past Performance and 3) Price. Technical Capability and Past Performance is significantly more important than price. This solicitation is issued as a Request for Quote (RFQ). The Food and Drug Administration (FDA) intends to award a purchase order for an aerosol detector. The Statement of Work is as follows: General Duties/Description of Work The FDA requires a “universal detector” for use with liquid chromatographic (LC) systems to analyze drug residues and xenobiotics in animal tissues, animal feed, and other matrices. The detector will be used primarily for analysis of non-volatile drugs and metabolites that have no specific UV absorbance and/or fluorescence characteristics. The detector response is independent of chemical structure. The compounds to be monitored are generated during the conduct of metabolism/pharmacokinetic studies that require compliance with Good Laboratory Practices (21 CFR part 58) and electronic records (21 CFR part 11). The detector must include the following components and meet these specifications: 1A charged aerosol detection process for measuring concentrations of non-volatile constituents in HPLC assays. 2Uses an ambient temperature nebulization system to evaporate the mobile phase and generate an aerosol stream composed of residue particles of all non-volatile constituents.. 3Uses a pressurized inert gas jet to transfer residue particles throughout the detection system. 4A “corona discharge is used to charge a secondary inert gas stream which merges the the primary particle stream to turbulently mix the gas ions with the aerosol particles. A unipolar electrical charge, proportional to the particle’s size, is transferred to the non-volatile residue particles, creating a “charged aerosol”. 5A charge-responsive collector is used to accumulate the electrical signals from the “charged aerosol” and a coupled electrical conductor senses the current generated by collected residue particles. The captured signal levels correspond directly to the concentration of the non-volatile analyte. There should be a dynamic range of four orders of magnitude 6The unit should have a graphical display coupled with a functional and lockable keypad for complete programable control and visual operating status. 7) The unit can be used with isocratic or gradient HPLC modes with both aqueous and volatile solvent-based mobile phases at flow rates of 0.3 - 2.0 mL/min. It should be compatible with systems using standard and narrow-bore configurations. 8)On-board microprocessor provides high resolution data (24-bit) and is enabled for external RS-232 control. 9)Software drivers for direct control and data acquisition via Agilent’s EZchrom Elite and/or Chemstation software. Delivery Address: 8401 Muirkirk Road Laurel, MD 20708 Equipment Use The detector must be delivered as a ready-to use units, which must include all the necessary communication cables, and interface cards for connection to the Agilent data system. The detector package must include an on-site installation with customer familiarization and a one-year warranty. Period of Performance 12 months from date of award. CCR: Vendors must be registered in the Central Contractor Register (CCR) prior to the award of a contract. You may register by going to www.ccr.gov. You will need your Dun & Bradstreet number and banking information. QUESTIONS DEADLINE: All questions are to be submitted via email to Jaclyn.Stielper@fda.hhs.gov no later than June 16, 2008, 4:30 PM EST. QUOTATIONS DUE: All quotations are due, via email to: Jaclyn.Stielper@fda.hhs.gov, no later than 4:30 PM, EST on June 18, 2008. PROVISIONS and CLAUSES: The provision at FAR 52.212-1, Instructions to Offerors Commercial Items applies to this solicitation. The following agenda has been attached to this provision: None. Offerors shall include a completed copy of the provision at FAR 52.212-3, Offeror Representations and Certifications Commercial Items. The clause at FAR 52.212-4, Contract Terms and Conditions, Commercial Items applies to this acquisition. The following agenda has been attached to the clause: None. The clause at FAR 52.212-5 Contract Terms and Conditions Required to Implement Statues or Executive Orders, Commercial Items applies to this acquisition. The following FAR clauses cited are applicable: FAR 52.217-8, FAR 52.217-9, FAR 52.222-26, FAR 52.222-35, FAR 52.222-36, and FAR 52.232-33. Clauses and provisions are incorporated by reference and apply to this acquisition. Responses to this notice must be sent via email to Jaclyn.Stielper@fda.hhs.gov. Telephone calls will not be accepted.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/1057621/listing.html)
- Place of Performance
- Address: 8401 Muirkirk Road, Laurel, Maryland, 20708, United States
- Zip Code: 20708
- Zip Code: 20708
- Record
- SN01834877-W 20090605/090603235332-1ebfdd4e97ab503ddb53473b0767d485 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |